Elcelyx Therapeutics, Inc. — Form D

Elcelyx Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-07. The offering totals $40.2M, of which $20.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (42)

Showing 25 of 42 people.

NameRoleLocation
Alain D BaronDirectorSan Diego, CA
RICHARD J BARRYDirectorCAMBRIDGE, MA
Ralph E ChristoffersonDirectorSan Diego, CA
Jim E GlasheenDirectorSan Diego, CA
Ginger E GrahamDirectorSan Diego, CA
Liang R TsuiDirectorSan Diego, CA
Alain D BaronExecutive OfficerSan Diego, CA
Martin R BrownExecutive OfficerChambersburg, PA
Mark R FinemanExecutive OfficerSan Diego, CA
Richard BarryDirectorOklahoma City, OK
Bosun HauDirectorSt. Louis, MO
Alain BaronDirectorSan Diego, CA
Alain BaronExecutive OfficerSan Diego, CA
Ginger GrahamDirectorSan Diego, CA
Jim GlasheenDirectorSan Diego, CA
Mark FinemanExecutive OfficerSan Deigo, CA
Christoffersen RalphDirectorSan Diego, CA
Sandy MahatmeDirectorSan Diego, CA
Liang TsuiDirectorSan Diego, CA
Jay SherwoodExecutive OfficerSan Diego, CA
Brook J ByersDirectorSan Diego, CA
Mark R WigginsExecutive OfficerSan Diego, CA
Ralph E ChristoffersenDirectorLouisville, CO
Ralph E ChristoffersenExecutive OfficerLouisville, CO
BROOK E BYERSDirectorSAN DIEGO, CA

Other filings by this issuer (9)

FiledFormOfferingSold
2018-11-07D$1.0M$476K
2015-02-19D$9.0M$5.8M
2014-02-21D/A$24.7M$24.7M
2013-02-26D$20.0M$12.0M
2012-12-20D/A$21.1M$21.1M
2012-08-13D/A$18.1M$18.1M
2011-05-10D/A$14.1M$14.1M
2011-01-26D$6.1M
2010-03-17D$2.2M$1.2M

More